Hypertension: Drug therapy options for older patients - Part 3

被引:0
|
作者
Butler, RN [1 ]
August, P
Ferdinand, KC
Phillips, RA
Roccella, EJ
机构
[1] Mt Sinai Med Ctr, Dept Geriatr & Adult Dev, New York, NY 10029 USA
[2] Int Longev Ctr US, New York, NY USA
[3] Cornell Univ Med Coll, New York, NY USA
[4] Cornell Univ, New York Hosp, Div Hypertens, New York, NY USA
[5] Xavier Univ, Coll Pharm, New Orleans, LA USA
[6] Heartbeats Life Ctr, New Orleans, LA USA
[7] Mt Sinai Med Ctr, Zena & Michael A Wiener Cardiovasc Inst, Hypertens Program, New York, NY 10029 USA
[8] Mt Sinai Med Ctr, Zena & Michael A Wiener Cardiovasc Inst, Cardiac Hlth Program, New York, NY 10029 USA
[9] NHLBI, Natl High Blood Pressure Educ Program, NIH, Bethesda, MD 20892 USA
来源
GERIATRICS-US | 1999年 / 54卷 / 07期
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
For the older patient with uncomplicated hypertension, JNC-VI recommends a low-dose thiazide diuretic as first-line drug therapy. If control is not achieved,it is often necessary to add a second or third agent. Cardioselective beta blockers are useful with concomitant coronary artery disease and are compelling post-MI. ACE inhibitors are useful in combination with a diuretic and for patients with congestive heart failure. Angiotensin II receptor blockers have some of the benefits of ACE inhibitors and a side effect profile similar to placebo. Alpha blockers can be very effective, especially when combined with calcium channel blockers or beta blockers. The dihydropyridine calcium antagonists have been shown to reduce morbidity and the incidence of stroke. Whatever the drug therapy, blood pressure controling older patients reduces the risk of stroke, coronary artery disease, and congestive heart failure.
引用
收藏
页码:27 / +
页数:5
相关论文
共 50 条
  • [31] Drug therapy options for oligoasthenoteratozoospermia syndrome
    Trottmann, M.
    Koehn, F. M.
    Dickmann, M.
    Stief, C. G.
    Becker, A. J.
    UROLOGE, 2011, 50 (01): : 8 - +
  • [32] Drug Treatment of Hypertension in Older Hypertensives
    Rashidi, Arash
    Wright, Jackson T.
    CLINICS IN GERIATRIC MEDICINE, 2009, 25 (02) : 235 - +
  • [33] Drug and therapy information service (ATIS):: Part 3 -: Therapeutic drug monitoring
    Postel, SC
    Tröger, U
    Bode-Böger, SM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 716 - 717
  • [34] Baroreflex activation therapy for patients with drug-resistant hypertension
    Alnima, Teba
    Kroon, Abraham A.
    de Leeuw, Peter W.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (08) : 955 - 962
  • [35] Hypertension in patients with diabetes - Strategies for drug therapy to reduce complications
    Sowers, JR
    Williams, M
    Epstein, M
    Bakris, G
    POSTGRADUATE MEDICINE, 2000, 107 (04) : 47 - +
  • [36] FACTORS INFLUENCING RESISTANCE TO DRUG THERAPY IN PATIENTS WITH ESSENTIAL HYPERTENSION
    Bezrodna, L.
    Svyshchenko, Y.
    Bezrodnyi, V.
    Matova, O.
    Kupchinska, O.
    Sheremet, M.
    JOURNAL OF HYPERTENSION, 2017, 35 : E302 - E303
  • [37] Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension
    Fagard, RH
    Staessen, JA
    Thijs, L
    Gasowski, J
    Bulpitt, CJ
    Clement, D
    de Leeuw, PW
    Dobovisek, J
    Jääskivi, M
    Leonetti, G
    O'Brien, E
    Palatini, P
    Parati, G
    Rodicio, JL
    Vanhanen, H
    Webster, J
    CIRCULATION, 2000, 102 (10) : 1139 - 1144
  • [38] Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension
    Fagard, R
    Staessen, J
    Thijs, L
    JOURNAL OF HYPERTENSION, 2000, 18 : S14 - S14
  • [39] Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension
    Fagard, RH
    Staessen, JA
    Thijs, L
    CIRCULATION, 2000, 102 (18) : 417 - 417